Glaxosmi.-Pharma Stock/Share Prices, Buy and Sell Glaxosmi.-Pharma BSE Stocks

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Large Cap

Invest

23 Sep 2019 | 11:08 AM

1,437.20

51.95 (3.75%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

-11.48%

Return (1Y)

Beaten S&P BSE Healthcare by 5.02%
More Volatile

1.44%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 0.43%
Not so consistent

5/12

Months

underperformed S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

1,695

1,131

News & Announcements

Glaxosmithkline Pharmaceuticals divests lands at Thane to Oberoi Realty
23 days ago

Glaxosmithkline Pharmaceuticals divests lands at Thane to Oberoi Realty

30 - Aug - 2019 12:00 AM | 23 days ago

Glaxosmithkline Pharmaceuticals has divested its lands at Thane admeasuring approximately 2,40,140 square meters in favour of Oberoi Realty for a total consideration of Rs. 889.50 crore. A small portion, bearing survey Nos. 182/2 & 182/3 admeasuring approximately 1,410 square meters, is excluded from this sale owing to a stay order passed by the Hon'ble Bombay High Court on 12 October 2017.
The Company has paid a sum of Rs. 337.46 crores towards obtaining all required statutory and regulatory approvals.
Powered by Capital Market - Live News
Glaxosmithkline Pharmaceuticals consolidated net profit rises 35.04% in the June 2019 quarter
62 days ago

Glaxosmithkline Pharmaceuticals consolidated net profit rises 35.04% in the June 2019 quarter

22 - Jul - 2019 12:00 AM | 62 days ago

Net profit of Glaxosmithkline Pharmaceuticals rose 35.04% to Rs 113.54 crore in the quarter ended June 2019 as against Rs 84.08 crore during the previous quarter ended June 2018. Sales rose 7.11% to Rs 787.97 crore in the quarter ended June 2019 as against Rs 735.65 crore during the previous quarter ended June 2018.
Particulars Quarter Ended
Jun. 2019 Jun. 2018 % Var.
Sales 787.97 735.65 7
OPM % 20.98 18.44 -
PBDT 195.17 153.44 27
PBT 176.11 142.08 24
NP 113.54 84.08 35
Powered by Capital Market - Live News
GlaxoSmithKline Pharmaceuticals to convene board meeting
86 days ago

GlaxoSmithKline Pharmaceuticals to convene board meeting

29 - Jun - 2019 12:00 AM | 86 days ago

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 July 2019.
Powered by Capital Market - Live News
GlaxoSmithKline Pharmaceuticals schedules AGM
123 days ago

GlaxoSmithKline Pharmaceuticals schedules AGM

22 - May - 2019 12:00 AM | 123 days ago

GlaxoSmithKline Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 22 July 2019.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -7.07% since past 3 Months
FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -16.11% since past 1 Year
MF shareholding in Glaxosmithkline Pharma Ltd has increased by 13.2% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Jun. 2019	Jun. 2018	% Var.
Sales	787.97	735.65	7
OPM %	20.98	18.44	-
PBDT	195.17	153.44	27
PBT	176.11	142.08	24
NP	113.54	84.08	35

General Notifications

My Notifications

Research Notifications

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE Pharmaceuticals, Large Cap

1,437.20 51.95 (3.75%)

News & Announcements

Price vs Volume

Stock Trivia

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Large Cap

1,437.20

51.95 (3.75%)